Surgery Partners (NASDAQ:SGRY) Shares Gap Up to $25.60

Surgery Partners, Inc. (NASDAQ:SGRY) shares gapped up before the market opened on Tuesday . The stock had previously closed at $25.60, but opened at $27.50. Surgery Partners shares last traded at $27.20, with a volume of 438,583 shares trading hands.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on SGRY shares. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Wednesday, April 10th. Barclays assumed coverage on shares of Surgery Partners in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price objective for the company. Citigroup reduced their target price on Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a report on Wednesday. Benchmark restated a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a research report on Wednesday, May 1st. Finally, StockNews.com upgraded Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus price target of $43.13.

Surgery Partners Trading Down 0.3 %

The stock has a market cap of $3.44 billion, a PE ratio of -270.90, a price-to-earnings-growth ratio of 2.24 and a beta of 2.75. The firm has a 50-day moving average price of $27.30 and a 200-day moving average price of $29.78. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.57 and a current ratio of 1.71.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, February 26th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The firm had revenue of $735.40 million for the quarter, compared to analysts’ expectations of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.22 earnings per share. As a group, equities analysts anticipate that Surgery Partners, Inc. will post 0.78 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In other Surgery Partners news, CEO Jason Eric Evans sold 4,840 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $29.71, for a total transaction of $143,796.40. Following the transaction, the chief executive officer now owns 459,670 shares in the company, valued at approximately $13,656,795.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Surgery Partners news, CFO David T. Doherty sold 1,020 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $34.93, for a total value of $35,628.60. Following the transaction, the chief financial officer now owns 74,209 shares of the company’s stock, valued at $2,592,120.37. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Jason Eric Evans sold 4,840 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $29.71, for a total transaction of $143,796.40. Following the sale, the chief executive officer now directly owns 459,670 shares of the company’s stock, valued at approximately $13,656,795.70. The disclosure for this sale can be found here. Insiders sold 14,664 shares of company stock worth $477,225 over the last quarter. 2.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. First Eagle Investment Management LLC increased its holdings in Surgery Partners by 16.5% in the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock worth $10,127,000 after acquiring an additional 48,100 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of Surgery Partners by 7.8% in the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock worth $405,000 after purchasing an additional 986 shares during the period. Capstone Investment Advisors LLC increased its stake in shares of Surgery Partners by 38.7% in the first quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock worth $273,000 after purchasing an additional 2,551 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Surgery Partners by 33.7% during the 1st quarter. BNP Paribas Financial Markets now owns 421,137 shares of the company’s stock valued at $12,563,000 after buying an additional 106,054 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in Surgery Partners by 16.3% in the 1st quarter. Principal Financial Group Inc. now owns 10,073 shares of the company’s stock worth $300,000 after buying an additional 1,409 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.